ZSTK
ZeroStack Corp.
Key Financials
Revenue
$35.7M
↓ 40.0%
Gross Profit
$1.6M
↓ 86.8%
Operating Income
$-154652000
↓ 888.5%
Net Income
$-15907000
↑ 72.1%
Total Liabilities
$59.7M
↑ 174.8%
Shareholders' Equity
$70.6M
↑ 1464.3%
Total Assets
$130.2M
↑ 396.6%
EPS (Diluted)
$-43.49
↓ 3245.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| ARS | 5/8/2026 | View on SEC |
| PRE 14A | 5/8/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 8-K | 5/6/2026 | View on SEC |
| 10-Q | 5/4/2026 | View on SEC |
| SCHEDULE 13D/A | 4/2/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ZSTK |
| Company Name | ZeroStack Corp. |
| CIK | 1790169 |
| Sector | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 5122 |
| SIC Description | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A6 |
| Phone | 416-861-2267 |